Basic Information
| LncRNA/CircRNA Name | DANCR |
| Synonyms | NA |
| Region | GRCh38_4:52712404-52720351 |
| Ensemble | ENSG00000226950 |
| Refseq | NR_024031 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | ovarian malignant tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | DANCR was upregulated in ovarian malignant tissues and ovarian cancer cells. |
| Pubmed ID | 31545000 |
| Year | 2019 |
| Title | LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145. |
External Links
| Links for DANCR | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |